Institutional investors hold a majority ownership of AMGN through the 82.05% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORDEA INVESTMENT MANAGEMENT AB ... Bought 292.4 Thousand shares of Amgen
NEW MEXICO EDUCATIONAL RETIREMEN... Bought 64.5 Thousand shares of Amgen
NATIONWIDE FUND ADVISORS Bought 51.0 Thousand shares of Amgen